Amarin Corporation/$AMRN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Amarin Corporation
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
Ticker
$AMRN
Sector
Primary listing
Employees
80
Headquarters
Dublin, Ireland
Website
AMRN Metrics
BasicAdvanced
$299m
-
-$1.30
0.80
-
Price and volume
Market cap
$299m
Beta
0.8
52-week high
$20.90
52-week low
$12.96
Average daily volume
77k
Financial strength
Current ratio
3.671
Quick ratio
2.482
Long term debt to equity
1.185
Total debt to equity
1.185
Interest coverage (TTM)
-3,419.86%
Profitability
EBITDA (TTM)
-21.094
Gross margin (TTM)
41.96%
Net profit margin (TTM)
-14.56%
Operating margin (TTM)
-12.85%
Effective tax rate (TTM)
-6.12%
Revenue per employee (TTM)
$2,330,000
Management effectiveness
Return on assets (TTM)
-2.31%
Return on equity (TTM)
-5.97%
Valuation
Price to revenue (TTM)
1.599
Price to book
0.67
Price to tangible book (TTM)
0.69
Growth
Revenue change (TTM)
-15.10%
Earnings per share change (TTM)
-74.13%
3-year revenue growth (CAGR)
-18.68%
10-year revenue growth (CAGR)
5.72%
3-year earnings per share growth (CAGR)
-11.73%
10-year earnings per share growth (CAGR)
-18.93%
AMRN News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.